Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
risperidone, Quantity: 2 mg
Amneal Pharma Australia Pty Ltd
Risperidone
Tablet, film coated
Excipient Ingredients: hypromellose; colloidal anhydrous silica; magnesium stearate; maize starch; lactose monohydrate; quinoline yellow; iron oxide red; microcrystalline cellulose; titanium dioxide; macrogol 400
Oral
60
(S4) Prescription Only Medicine
Risperidone CH is indicated for the treatment of schizophrenia and related psychoses. Risperidone CH is indicated for the treatment of behavioural disturbances in dementia. Risperidone CH is indicated for the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent. (See Clinical Trials for maintenance data).
Visual Identification: Orange, film-coated, oblong tablet engraved with "R", a breakline and "2" on one side and a plain face on the other.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2012-09-26